Cargando…
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
In breast cancer it has been proposed that the presence of cancer stem cells may drive tumor initiation, progression and recurrences. IL-8, up-regulated in breast cancer, and associated with poor prognosis, increases CSC self-renewal in cell line models. It signals via two cell surface receptors, CX...
Autores principales: | Brandolini, Laura, Cristiano, Loredana, Fidoamore, Alessia, De Pizzol, Maria, Di Giacomo, Erica, Florio, Tiziana Marilena, Confalone, Giuseppina, Galante, Angelo, Cinque, Benedetta, Benedetti, Elisabetta, Ruffini, Pier Adelchi, Cifone, Maria Grazia, Giordano, Antonio, Alecci, Marcello, Allegretti, Marcello, Cimini, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791238/ https://www.ncbi.nlm.nih.gov/pubmed/26517518 |
Ejemplares similares
-
CXCR1/2 pathways in paclitaxel-induced neuropathic pain
por: Laura, Brandolini, et al.
Publicado: (2017) -
Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
por: Benedetti, Elisabetta, et al.
Publicado: (2015) -
Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
por: Fidoamore, Alessia, et al.
Publicado: (2017) -
CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
por: Castelli, Vanessa, et al.
Publicado: (2021) -
Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain
por: Brandolini, Laura, et al.
Publicado: (2019)